We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$9.95B
Cap. Flow %
3.83%
Top 10 Hldgs %
14.4%
Holding
8,581
New
810
Increased
3,919
Reduced
2,793
Closed
626

Sector Composition

Rank Sector Weight
1 Technology 9.74%
2 Financials 7.41%
3 Healthcare 6.49%
4 Consumer Discretionary 5.87%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFBW
7376
DELISTED
FFBW, Inc. Common Stock
FFBW
$5K ﹤0.01%
611
+591
+2,955% +$5.29K
AHPI
7377
DELISTED
Allied Healthcare Products
AHPI
$5K ﹤0.01%
2,673
-5,715
-68% -$10.1K
OTIC
7378
DELISTED
Otonomy, Inc.
OTIC
$5K ﹤0.01%
1,735
-21
-1% -$56
ZVO
7379
DELISTED
Zovio Inc. Common Stock
ZVO
$5K ﹤0.01%
+1,297
New +$6.46K
VOLT
7380
DELISTED
Volt Information Sciences, Inc.
VOLT
$5K ﹤0.01%
+1,005
New +$4.55K
ADMS
7381
DELISTED
Adamas Pharmaceuticals
ADMS
$5K ﹤0.01%
865
-181
-17% -$1.04K
TRIL
7382
DELISTED
Trillium Therapeutics Inc.
TRIL
$5K ﹤0.01%
15,065
-1,441
-9% -$743
TDACU
7383
DELISTED
Trident Acquisitions Corp. Units
TDACU
$5K ﹤0.01%
470
-1,600
-77% -$16.6K
GUDB
7384
DELISTED
Sage ESG Intermediate Credit ETF
GUDB
$5K ﹤0.01%
99
AKCA
7385
DELISTED
Akcea Therapeutics Inc
AKCA
$5K ﹤0.01%
200
FLAT
7386
DELISTED
iPath US Treasury Flattener ETN
FLAT
$5K ﹤0.01%
69
ALO
7387
DELISTED
Alio Gold Inc
ALO
$5K ﹤0.01%
6,025
+4,525
+302% +$2.97K
JPED
7388
DELISTED
JPMorgan Event Driven ETF
JPED
$5K ﹤0.01%
+200
New +$5.11K
JNMF
7389
DELISTED
WisdomTree Japan Multifactor Fund
JNMF
$5K ﹤0.01%
196
DTO
7390
DELISTED
DB Crude Oil Double Short Exchange Traded Notes due June 1, 2038
DTO
$5K ﹤0.01%
96
-719
-88% -$38.2K
OMOM
7391
DELISTED
Invesco Russell 1000 Momentum Factor ETF
OMOM
$5K ﹤0.01%
186
DEMG
7392
DELISTED
Xtrackers FTSE Emerging Comprehensive Factor ETF
DEMG
$5K ﹤0.01%
+193
New +$4.7K
AWSM
7393
DELISTED
Cool Holdings Inc. Common Stock
AWSM
$5K ﹤0.01%
3,023
+1,351
+81% +$3.28K
FNG
7394
DELISTED
AdvisorShares New Tech and Media ETF
FNG
$5K ﹤0.01%
+403
New +$5.67K
XYN
7395
DELISTED
Xynomic Pharmaceuticals Holdings, Inc. Common Stock
XYN
$5K ﹤0.01%
+1,357
New +$4.41K
CPAH
7396
DELISTED
Counterpath Corp
CPAH
$5K ﹤0.01%
3,496
+821
+31% +$1.36K
YELL
7397
DELISTED
Yellow Corporation Common Stock
YELL
$5K ﹤0.01%
1,248
+818
+190% +$4.73K
VRML
7398
DELISTED
Vermillion, Inc.
VRML
$5K ﹤0.01%
+5,074
New +$5.88K
ZNB
7399
Zeta Network Group
ZNB
$551K
0
ANY icon
7400
Sphere 3D
ANY
$18.5M
$4K ﹤0.01%
38
-29
-43% -$4.3K

Similar funds

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $9.95B of net new capital in Q2 2019, opening 810 new positions and adding to 3,919 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 810 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.